University Medicine Cluster, National University Hospital, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
Laboratory for Computational Physiology, Harvard-MIT Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
J Thromb Thrombolysis. 2021 Aug;52(2):654-661. doi: 10.1007/s11239-020-02368-1. Epub 2021 Jan 2.
Left ventricular thrombus (LVT) is a common complication of acute myocardial infarction and is associated with morbidity from embolic complications. Predicting which patients will develop death or persistent LVT despite anticoagulation may help clinicians identify high-risk patients. We developed a random forest (RF) model that predicts death or persistent LVT and evaluated its performance. This was a single-center retrospective cohort study in an academic tertiary center. We included 244 patients with LVT in our study. Patients who did not receive anticoagulation (n = 8) or had unknown (n = 31) outcomes were excluded. The primary outcome was a composite outcome of death, recurrent LVT and persistent LVT. We selected a total of 31 predictors collected at the point of LVT diagnosis based on clinical relevance. We compared conventional regularized logistic regression with the RF algorithm. There were 156 patients who had resolution of LVT and 88 patients who experienced the composite outcome. The RF model achieved better performance and had an AUROC of 0.700 (95% CI 0.553-0.863) on a validation dataset. The most important predictors for the composite outcome were receiving a revascularization procedure, lower visual ejection fraction (EF), higher creatinine, global wall motion abnormality, higher prothrombin time, higher body mass index, higher activated partial thromboplastin time, older age, lower lymphocyte count and higher neutrophil count. The RF model accurately identified patients with post-AMI LVT who developed the composite outcome. Further studies are needed to validate its use in clinical practice.
左心室血栓(LVT)是急性心肌梗死的常见并发症,与栓塞并发症的发病率有关。预测哪些患者尽管接受抗凝治疗仍会发生死亡或持续性 LVT,可能有助于临床医生识别高危患者。我们开发了一种随机森林(RF)模型来预测死亡或持续性 LVT,并评估了其性能。这是一项在学术性三级中心进行的单中心回顾性队列研究。我们的研究纳入了 244 例 LVT 患者。排除未接受抗凝治疗的患者(n=8)或结局未知的患者(n=31)。主要结局是死亡、复发性 LVT 和持续性 LVT 的复合结局。我们根据临床相关性选择了在 LVT 诊断时收集的总共 31 个预测因子。我们比较了常规正则逻辑回归与 RF 算法。共有 156 例患者 LVT 得到缓解,88 例患者发生复合结局。RF 模型在验证数据集上的表现更好,AUROC 为 0.700(95%CI 0.553-0.863)。对于复合结局最重要的预测因子是接受血运重建术、较低的视觉射血分数(EF)、较高的肌酐、整体壁运动异常、较高的凝血酶原时间、较高的体重指数、较高的部分凝血活酶时间、年龄较大、较低的淋巴细胞计数和较高的中性粒细胞计数。RF 模型能够准确识别发生 AMI 后 LVT 且发生复合结局的患者。需要进一步的研究来验证其在临床实践中的应用。